- Public Health ×
January 20, 2020
The Microbiology Society and the Healthcare Infection Society (HIS) co-hosted a collaborative one-day workshop, titled ‘Bridging the clinical-research gap’ in London on 21 November 2019. The aim of this event was to bring academic and clinical microbiologists together to find ways to collaborate meaningfully, with an ultimate goal of improving the translation of research in infection prevention and control. Here, Dr Karen Robinson discusses her experience at the event.
October 23, 2019
In this blog, Professor Garry Blakely, from the University of Edinburgh's School of Biological Sciences, discusses carbapenemase-producing bacteria and the importance of surveillance. In August 2019, Professor Blakely attended a Public Health England (PHE) steering group with a number of clinicians and diagnostic staff to discuss the limitations and effects that reporting infections from carbapenemase-producing bacteria could have on healthcare systems.
March 22, 2019
Sunday 24 March marks World Tuberculosis Day. On this day in 1882, Robert Koch announced he had discovered the causative agent of tuberculosis (TB), which was a major development in understanding the disease and working towards finding treatment options. In this post, we discuss TB research with Professor Tanya Parrish, Editor-in-Chief of the Society's flagship journal, Microbiology, and Head of the TB Discovery Research Group at the Infectious Disease Research Institute (IDRI) in the US.
February 22, 2019
Last year the Microbiology Society submitted a joint response with the Society for Applied Microbiology (SfAM) to the Health and Social Care Select Committee’s inquiry into antimicrobial resistance. On the 24th January 2019, the UK government launched its strategy to tackle antimicrobial resistance (AMR). In this blog we highlight key points in the UK AMR Strategy and research priorities.
February 8, 2019
On 17-18 January, Microbiology Society member Dr Rachel Exley, lecturer at Oxford University, attended the Wellcome Trust to celebrate 10 years of e-Bug. The event focused on public education of antimicrobial resistance (AMR). Here, Rachel discusses her experience at the event.
January 17, 2019
In 2017 the World Health Organisation (WHO) published the 12 Priority Pathogens. This list is a catalogue of the pathogens they believe pose the greatest threat to human health. The list draws attention to the growing incidence of antimicrobial resistance (AMR) evolving in bacteria, a development that is particularly worrying as genetic material can be passed between different species of bacteria, spreading resistance to life-saving antibiotics.
November 14, 2018
Continuing on our New Antibiotics Needed blog series, today we will be exploring β-lactamase-producing and carbapenemase-producing Enterobacteriaceae.
October 16, 2018
This September, the United Nations convened a high-level meeting aimed at addressing the global tuberculosis (TB) epidemic. Delegates heard from heads of state and political leaders, but one of the most powerful speakers was Nandita Venkatesan. Shortly after graduating from university in 2007, Nandita was diagnosed with TB. At the high-level meeting, she spoke of her years spent battling the disease and the devastation she felt when she lost her hearing as a side effect of the essential, lifesaving treatments she had to take.